You can start a fundraiser or donate today to celebrate the life of Angela Anderson and support SJS/TEN research led by Elizabeth Phillips, M.D. at Vanderbilt University Medical Center. Click here to visit the new site. http://give.vanderbilthealth.org/AWA
Read MoreWe were honored to once again visit the research lab of Dr. Elizabeth Phillips at Vanderbilt University Medical Center in Nashville. The research is tedious, complex and encouraging! There are currently 24 sites across the US and Canada focused on the research of drug induced disease. Dr. Phillips’ Laboratory works closely with Murdoch University in … Read more
Read MoreThe mission of the SJS/TEN research program at VUMC is to 1) improve preventive efforts and facilitate translation of genetic screening into the clinical and pre-clinical setting to prevent SJS/TEN through excluding patients at risk from high risk drugs and facilitating the development of safer drugs less likely to cause SJS/TEN. 2) Identify biomarkers associated … Read more
Read MoreThis is the speech I gave at the Genomic Medicine Meeting in Silver Spring, Maryland on May 2, 2017. I was invited by Duke University’s School of Medicine’s Center for Applied Genomics and Precision Medicine and The National Institute of Health to tell “Angela’s Story” It was not an easy story to tell but it … Read more
Read MoreBy Sheena Faherty, Ph.D. Science Writer, NHGRI Angela Anderson, a 22-year-old woman, fell victim to the fatal genetic condition, Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis, or SJS/TEN. Photo credit: Paul and Wanpen Anderson. “Angela was unique. She was a trendsetter … one in a million. The disease that took her was one in a million. Even in … Read more
Read More